DrugSalesDB – 2026 Q1 Edition

DescriptionQuarterly pharmaceutical product sales (past 8 quarters) from the world's leading pharmaceutical companies, standardized into a single database with an interactive dashboard.Instead of collecting product sales from dozens of investor presentations, annual reports, earnings releases and SEC filings, DrugSalesDB brings everything together in a consistent format for analysis.Ideal for: Biotech investors Equity research Pharmaceutical professionals Business development & strategy Healthcare consultants Students preparing for pharma interviews Included Interactive dashboard (offline HTML) Source Data (Excel/CSV) Quarterly product sales (past 8 quarters or more) Historical quarterly data Standardized product names Unified currency (USD) Companies included AbbVie Amgen Astellas Pharma AstraZeneca Bayer Bristol Myers Squibb Daiichi Sankyo Eli Lilly Gilead Sciences Johnson & Johnson Kyowa Kirin Merck & Co. Merck KGaA Novartis Novo Nordisk Ono Pharmaceutical Otsuka Holdings Pfizer Regeneron Pharmaceuticals Roche Sanofi Santen Pharmaceutical Shionogi Sumitomo Pharma Takeda Vertex Pharmaceuticals argenx Designed forWhether you're comparing blockbuster drugs, tracking commercial launches, preparing investment research, or following quarterly earnings, DrugSalesDB provides a consistent, easy-to-use dataset that saves hours of manual data collection.

Found on Devadex — the discovery index for independent software the big search engines bury. More from gumroad.

Report this listing